http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012144543-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-88 |
| filingDate | 2011-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012144543-A |
| titleOfInvention | 3- (HETEROARYLAMINO) -1,2,3,4-TETRAHYDRO-9H-CARBAZOLE DERIVATIVES AND THEIR APPLICATION AS PROSTAGLANDINE D2 RECEPTOR MODULATORS |
| abstract | 1. The compound of formula (I) in which R is hydrogen, (C — C) alkyl, (C — C) alkoxy, halogen, trifluoromethoxy or trifluoromethyl, R is hydrogen, (C — C) alkyl, (C — C) alkoxy ( C-C) alkyl, (C-C) fluoroalkyl or (C-C) cycloalkyl (C-C) alkyl, and R is a heteroaryl group which is unsubstituted or mono-, di- or trisubstituted, where the substituents are independently selected from the group including halogen, (C — C) alkyl, (C — C) picloalkyl, (C — C) alkoxy, (C — C) fluoroalkyl and phenyl, or a salt of such a compound. 2. A compound according to claim 1, wherein R is fluorine, chlorine or trifluoromethyl, R is hydrogen, methyl, 2-methoxyethyl or cyclopropylmethyl, and R is a heteroaryl group which is a monosubstituted fluorine or chlorine, or a salt of such a compound. A compound according to claim 1, wherein R is fluorine, R is hydrogen or methyl, and R is a heteroaryl group that is unsubstituted or monosubstituted by fluorine, chlorine or trifluoromethyl, or a salt of such a compound. A compound according to claim 1, wherein R is a halogen or a salt of such a compound. A compound according to any one of claims 1 or 4, wherein R is hydrogen, methyl, ethyl, n-propyl, 2-methoxyethyl, 2,2-difluoroethyl or cyclopropylmethyl, or a salt of such a compound. A compound according to any one of claims 1 to 4, in which R is methyl, or a salt of such a compound. A compound according to any one of claims 1 or 4, in which R represents a heteroaryl group that is unsubstituted or monosubstituted by a halogen, methoxy group, trifluoromethyl or phenyl, or a salt of such a compound. The compound according to any one of claims 1, 3 or 4, in |
| priorityDate | 2010-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 152.